ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 18 Issue : 1 Year: 2017
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism? [Anatol J Cardiol]
Anatol J Cardiol. 2017; 18(1): 77-79 | DOI: 10.14744/AnatolJCardiol.2017.7805  

Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?

Marija Vavlukis, Irina Kotlar, Hajber Taravari, Lidija Poposka, Sasko Kedev
University Clinic of Cardiology, Medical Faculty, University Ss' Cyril and Methodius; Skopje-Republic of Macedonia



x-_5n5BQNf8



Marija Vavlukis, Irina Kotlar, Hajber Taravari, Lidija Poposka, Sasko Kedev. Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?. Anatol J Cardiol. 2017; 18(1): 77-79

Corresponding Author: Marija Vavlukis, Macedonia


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright 2016 Turkish Society of Cardiology